Targeting cancer stem cells to suppress acquired chemotherapy resistance
2013 · Oncogene · 241 citations
https://doi.org/10.1038/onc.2013.411
S
Samuel J. Vidal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.5K
Citations
10
h-index
10
i10-index
Samuel J. Vidal is an academic researcher from University of the Amazon. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Prostate Cancer Treatment and Research. The author has an h-index of 10, co-authored 29 publications.
ORCID: 0000-0002-3419-0469Papers by this author
worksLong-acting capsid inhibitor protects macaques from repeat SHIV challenges
2021 · Nature · 24 citations
https://doi.org/10.1038/s41586-021-04279-4
Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model
2023 · iScience · 8 citations
https://doi.org/10.1016/j.isci.2023.106963
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat